J H Moon1, J H Moon1, K M Kim, S H Choi, S Lim, K S Park, K W Kim, H C Jang. 1. Hak Chul Jang, MD, PhD, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro, 173 beon-gil, Bundang-gu, Seongnam, Gyeonggi-do, 463-707, Korea, Tel: +82-31-787-7005, Fax: +82-31-787-4051, E-mail: janghak@snu.ac.kr.
Abstract
OBJECTIVES: We investigated the association between the indices of sarcopenia and future risk of cognitive impairment in older adults. DESIGN: Community-based prospective cohort study. SETTING: Community. PARTICIPANTS: A total of 297 participants aged ≥65 years without cognitive impairment at baseline (mean age, 71.9 ± 6.6 years; men:women, 158:139) and who underwent cognitive evaluation at the 5-year follow-up. MEASUREMENTS: Sarcopenia parameters including appendicular lean mass (ALM), handgrip strength, and the Short Physical Performance Battery (SPPB) score at baseline were compared according to the later progression of mild cognitive impairment (MCI) and/or dementia. The operational criteria suggested by the Foundation for the National Institutes of Health Sarcopenia Project were used. We performed multivariate logistic regression analysis to identify the independent indicators of the progression of cognitive impairment. RESULTS: Among the 297 participants, 242 (81.5%) remained cognitively normal (nonprogression group), whereas 55 (18.5%) showed progression of cognitive impairment (50 subjects (16.8%) to MCI and 5 subjects (1.7%) to dementia) (progression group). Compared with the nonprogression group, subjects in the progression group were older, had a lower educational level, and had lower physical function as assessed by the SPPB; a higher percentage were depressed. Other baseline markers of sarcopenia, including the ALM-to-body mass index ratio and handgrip strength did not differ significantly between the groups. The association between a low SPPB score (<9) and progression of cognitive impairment was maintained after adjustment for conventional risk factors for cognitive impairment (hazard ratio 2.222, 95% confidence interval 1.047-4.716, P = 0.038). CONCLUSION: Decreased physical performance, as assessed by the SPPB, but not other markers of sarcopenia, was independently associated with the risk of later cognitive impairment in older adults.
OBJECTIVES: We investigated the association between the indices of sarcopenia and future risk of cognitive impairment in older adults. DESIGN: Community-based prospective cohort study. SETTING: Community. PARTICIPANTS: A total of 297 participants aged ≥65 years without cognitive impairment at baseline (mean age, 71.9 ± 6.6 years; men:women, 158:139) and who underwent cognitive evaluation at the 5-year follow-up. MEASUREMENTS: Sarcopenia parameters including appendicular lean mass (ALM), handgrip strength, and the Short Physical Performance Battery (SPPB) score at baseline were compared according to the later progression of mild cognitive impairment (MCI) and/or dementia. The operational criteria suggested by the Foundation for the National Institutes of Health Sarcopenia Project were used. We performed multivariate logistic regression analysis to identify the independent indicators of the progression of cognitive impairment. RESULTS: Among the 297 participants, 242 (81.5%) remained cognitively normal (nonprogression group), whereas 55 (18.5%) showed progression of cognitive impairment (50 subjects (16.8%) to MCI and 5 subjects (1.7%) to dementia) (progression group). Compared with the nonprogression group, subjects in the progression group were older, had a lower educational level, and had lower physical function as assessed by the SPPB; a higher percentage were depressed. Other baseline markers of sarcopenia, including the ALM-to-body mass index ratio and handgrip strength did not differ significantly between the groups. The association between a low SPPB score (<9) and progression of cognitive impairment was maintained after adjustment for conventional risk factors for cognitive impairment (hazard ratio 2.222, 95% confidence interval 1.047-4.716, P = 0.038). CONCLUSION: Decreased physical performance, as assessed by the SPPB, but not other markers of sarcopenia, was independently associated with the risk of later cognitive impairment in older adults.
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: E Kelaiditi; M Cesari; M Canevelli; G Abellan van Kan; P-J Ousset; S Gillette-Guyonnet; P Ritz; F Duveau; M E Soto; V Provencher; F Nourhashemi; A Salvà; P Robert; S Andrieu; Y Rolland; J Touchon; J L Fitten; B Vellas Journal: J Nutr Health Aging Date: 2013-09 Impact factor: 4.075
Authors: Thuy-Tien Dam; Katherine W Peters; Maren Fragala; Peggy M Cawthon; Tamara B Harris; Robert McLean; Michelle Shardell; Dawn E Alley; Anne Kenny; Luigi Ferrucci; Jack Guralnik; Douglas P Kiel; Steve Kritchevsky; Maria T Vassileva; Stephanie Studenski Journal: J Gerontol A Biol Sci Med Sci Date: 2014-05 Impact factor: 6.053
Authors: B Fougère; M Cesari; H Arai; J Woo; R A Merchant; L Flicker; A Cherubini; J M Bauer; B Vellas; J E Morley Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield Journal: Ann Med Date: 2018-09-12 Impact factor: 4.709
Authors: Joon Ho Moon; Kyoung Min Kim; Jung Hee Kim; Jae Hoon Moon; Sung Hee Choi; Soo Lim; Jae-Young Lim; Ki Woong Kim; Kyong Soo Park; Hak Chul Jang Journal: PLoS One Date: 2016-11-10 Impact factor: 3.240
Authors: Xinji Liu; Jun Chen; Renwen Geng; Rong Wei; Peiru Xu; Beijing Chen; Kaiyong Liu; Linsheng Yang Journal: J Int Med Res Date: 2020-06 Impact factor: 1.671
Authors: Il-Young Jang; Hee-Won Jung; Chang Ki Lee; Sang Soo Yu; Young Soo Lee; Eunju Lee Journal: Clin Interv Aging Date: 2018-01-12 Impact factor: 4.458
Authors: A Patel; K A Jameson; M H Edwards; K Ward; C R Gale; C Cooper; Elaine M Dennison Journal: Arch Osteoporos Date: 2018-04-24 Impact factor: 2.617
Authors: Yeonjung Ha; Daejung Kim; Seungbong Han; Young Eun Chon; Yun Bin Lee; Mi Na Kim; Joo Ho Lee; Hana Park; Kyu Sung Rim; Seong Gyu Hwang Journal: Cancer Res Treat Date: 2017-09-04 Impact factor: 4.679